Translate
Rocket Pharmaceuticals Inc
About
Rocket Pharmaceuticals Inc (NASDAQ:RCKT) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 27 2026
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
Feb 26 2026
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress
Jan 5 2026
Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Nov 25 2025
Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference
Nov 13 2025
Neurvati Neurosciences Appoints Carlos Martin as Chief Commercial Officer
Financials
Revenue
$0
Market Cap
$385.42 M
EPS
-2.01